SenesTech, Inc. (SNES)
NASDAQ: SNES · Real-Time Price · USD
1.640
-0.040 (-2.38%)
At close: Apr 2, 2026, 4:00 PM EDT
1.620
-0.020 (-1.22%)
After-hours: Apr 2, 2026, 4:10 PM EDT
Company Description
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control.
The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption.
It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice.
The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
SenesTech, Inc.
| Country | United States |
| Founded | 2004 |
| IPO Date | Dec 8, 2016 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 24 |
| CEO | Joel Fruendt |
Contact Details
Address: 13430 North Dysart Road, Suite 105 Surprise, Arizona 85379 United States | |
| Phone | 928 779 4143 |
| Website | senestech.com |
Stock Details
| Ticker Symbol | SNES |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001680378 |
| CUSIP Number | 81720R208 |
| ISIN Number | US81720R6045 |
| Employer ID | 20-2079805 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Joel L. Fruendt | Chief Executive Officer and President |
| Dr. Jamie Bechtel J.D., Ph.D. | Interim Executive Chair |
| Thomas C. Chesterman M.B.A. | Executive Vice President, Chief Financial Officer, Treasurer and Secretary |
| Michael Edell | Interim Chief Operating Officer |
| Bryan Di Menna | Vice President of Sales |
| Robert Blum | Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 18, 2026 | SCHEDULE 13G/A | Filing |
| Mar 13, 2026 | 10-K | Annual Report |
| Mar 12, 2026 | 8-K | Current Report |
| Feb 2, 2026 | SCHEDULE 13G/A | Filing |
| Jan 28, 2026 | 8-K/A | [Amend] Current report |
| Jan 28, 2026 | 8-K | Current Report |
| Nov 24, 2025 | SCHEDULE 13G | Filing |
| Nov 14, 2025 | 8-K | Current Report |
| Nov 10, 2025 | 10-Q | Quarterly Report |
| Nov 10, 2025 | 8-K | Current Report |